Neuroone Medical Technologies (NMTC) Change in Acquisitions & Divestments (2022 - 2023)
Neuroone Medical Technologies (NMTC) posted Change in Acquisitions & Divestments of $1.0 million for Q2 2023, down 50.0% on a QoQ basis from $2.0 million in Q1 2023.
Neuroone Medical Technologies (NMTC) Change in Acquisitions & Divestments (2022 - 2023) Analysis & Trends
Neuroone Medical Technologies' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $1.0 million for Q2 2023.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $1.0 million in Q2 2023, while the trailing twelve-month figure through Sep 2023 was $4.5 million (changed N/A YoY) and the FY2023 annual result came in at $4.5 million, up 800.0% from the prior year.
- Change in Acquisitions & Divestments was $1.0 million for Q2 2023 at Neuroone Medical Technologies, down from $2.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $2.0 million in Q1 2023 and bottomed at $1.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |